Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion type Assertion NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_head.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion description "[Epigenetic silencing of SFRP5 is related to malignant phenotype and chemoresistance of ovarian cancer through Wnt signaling pathway.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_provenance.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion evidence source_evidence_literature NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_provenance.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion SIO_000772 19957335 NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_provenance.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion wasDerivedFrom befree-20150227 NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_provenance.
- NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_assertion wasGeneratedBy ECO_0000203 NP691302.RAGMRVJghKk9Nj_xSnRfjH9w9jp6eFv8gBBDQ9dG32LNI130_provenance.